Bio-Techne SVP General Counsel Shane Bohnen Stock Transactions and Holdings

This Form 4 filing reports transactions by Shane Bohnen, SVP - General Counsel of Bio-Techne Corp (TECH), on April 3, 2026. Bohnen acquired 2,259 shares of common stock through the vesting of restricted stock units (RSUs) at $0 per share and simultaneously disposed of 740 shares at $53.13 per share. Following these transactions, his direct ownership stands at 5,904 shares of common stock. The filing also details Bohnen's extensive derivative holdings including stock options with various expiration dates through 2035, restricted stock units, and performance-based equity awards. The options have exercise prices ranging from $47.60 to $120.46, with significant holdings in both time-based and performance-based equity compensation. This filing provides transparency into executive compensation and equity ownership changes for a key officer of the biotechnology company.